David A. Wenger, PhD

David A. Wenger, PhD

Contact Dr. Wenger

1020 Locust Street
Room 394
Philadelphia, PA 19107

(215) 955-1666
(215) 955-9554 fax

Most Recent Peer-reviewed Publications

  1. Biochemical and clinical response after umbilical cord blood transplant in a boy with early childhood-onset beta-mannosidosis
  2. A closer look at ARSA activity in a patient with metachromatic leukodystrophy
  3. Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months 11 Medical and Health Sciences 1109 Neurosciences
  4. AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease)
  5. Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease
  6. GM2 Gangliosidosis in Shiba Inu Dogs with an In-Frame Deletion in HEXB
  7. Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State
  8. Krabbe disease: One Hundred years from the bedside to the bench to the bedside
  9. Expression of individual mutations and haplotypes in the galactocerebrosidase gene identified by the newborn screening program in New York State and in confirmed cases of Krabbe's disease
  10. A patient with atypical multiple sulfatase deficiency
  11. Newborn screening for Krabbe disease in New York State: The first eight years' experience
  12. Long-term improvements in lifespan and pathology in CNS and PNS after BMT plus one intravenous injection of AAVrh10-GALC in twitcher mice
  13. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy
  14. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features
  15. Reprint of: Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases
  16. Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases
  17. Krabbe Disease: Globoid Cell Leukodystrophy
  18. Krabbe disease: Are certain mutations disease-causing only when specific polymorphisms are present or when inherited in trans with specific second mutations?
  19. Iminosugar-based galactoside mimics as inhibitors of galactocerebrosidase: SAR studies and comparison with other lysosomal galactosidases
  20. Lysosomal storage diseases: Heterogeneous group of disorders